Children’s Hospital of Philadelphia (CHOP) is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome (TIS).

Advanced bronchoscopy techniques are allowing us to diagnose and treat many pulmonary conditions that previously required invasive surgery. 

A fetus with cystic fibrosis was treated in utero with elexacaftor/tezacaftor/ivacaftor to prevent meconium ileus. 

The following CHOP clinicians recently joined our team.

In recent years, recognition of autism and autism spectrum disorders (ASD) in the general population has burgeoned.

Christopher S. Thom, MD, PhD, is an attending physician and principal investigator in the Division of Neonatology at Children’s Hospital of Philadelphia (CHOP).

It’s an exciting time for research in the bronchopulmonary dysplasia (BPD) population here at Children’s Hospital of Philadelphia (CHOP). 

The increase in opioid use disorder among adults across the U.S. includes pregnant people, with an associated increase in substance-exposed newborns.

Our second inpatient location — the Middleman Family Pavilion on CHOP’s campus in King of Prussia, Pa., a suburb just outside of Philadelphia — opened in early 2022. 

Quick-Mitome, developed by an international consortium of mitochondrial disease specialists, is available for non-commercial, non-clinical research.